FDA Brief

Company record

Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre.

Warning letters

  1. Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre

    FDA warned clinical investigator Dr. Mukesh Chandre over informed consent failures in a doxorubicin liposome bioequivalence study.

    High risk